Webber, M M <br/><br/>
Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).  [electronic resource] 

 -  Clinical & experimental metastasis  May 1999 
 - 255-63 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0262-0898 
<br/><br/><label>Standard No.: </label>10.1023/a:1006665616932  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Carcinoma--metabolism<br/>Cell Division--drug effects<br/>Cell Movement--drug effects<br/>Epithelial Cells--metabolism<br/>Fenretinide--pharmacology<br/>Humans<br/>Male<br/>Neoplasm Invasiveness<br/>Phenotype<br/>Prostatic Neoplasms--metabolism<br/>Receptors, Retinoic Acid--biosynthesis<br/>Tumor Cells, Cultured<br/>Up-Regulation--drug effects<br/>Vimentin--biosynthesis